Headquarters: Bedford, Massachusetts, United States
Trade prices
Volume:
Market Cap:12.83M
Prev closed:7.55
Open:7.51
High:7.59
Low:6.44
52 week low:5.04
52 week high:20.5
Dividends:No Dividends
Next ER:February 13, 2023 Before Market Opens
Top Stories (KLDO)
Company Profile
Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health. The Company has built a proprietary product platform to enable the rapid and cost-efficient discovery and development of novel Microbiome Metabolic Therapies (MMT?). MMTs are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the gut?s existing microbes. Kaleido is advancing a broad pipeline of MMT candidates with the potential to address a variety of diseases and conditions with significant unmet patient needs.
Talk about Kaleido Biosciences below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis
